Skip to main content
SpringerLink
Log in

Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations

  • Review article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Aim

Mediterranean diet (MD) is a healthful dietary pattern with benefits for prevention of metabolic diseases including non-alcoholic fatty liver disease (NAFLD). In the current meta-analysis, we assessed the association between MD and liver steatosis and cardiometabolic risk factors in patients with NAFLD.

Methods

PubMed, Scopus, and Embase were searched to find observational and clinical studies on the issue. No restriction on date and language was made. Outcomes included body mass index (BMI), waist circumference, blood pressure, triglycerides (TG), cholesterol fractions, glucose, insulin, insulin resistance, and liver transaminases.

Results

Seven observational reports and 6 trials met our inclusion criteria and entered in the meta-analysis. In observational studies, there was an inverse association between MD and NAFLD (effect size (ES) = 0.95; 95% CI: 0.90, 1.00; P = 0.05). In trials, subgroup analysis based on the method of liver examination showed effectiveness of MD on steatosis examined by magnetic resonance spectroscopy (P < 0.002; n = 2) but not by ultrasound (P = 0.08; n = 2). MD also showed a significant decreasing effect on BMI (ES = −1.23 kg/m2; 95% CI: −2.38, −0.09), plasma triglycerides (ES = −33.01 mg/dL; 95% CI: −52.84, −13.18), and HOMA-IR (ES = -0.94; 95% CI: −1.29, −0.58) but no significant effect was observed in waist circumference, cholesterol fractions, glucose and insulin, and liver transferases.

Conclusion

Overall, available data from observational and clinical studies indicated a trend for the relationship between MD and hepatic steatosis. Improvement in the most important risk factors of NAFLD, i.e. BMI, serum triglycerides, and insulin resistance, may be involved in such relationship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet; a literature review. Nutrients. 2015;7(11):9139–53. https://doi.org/10.3390/nu7115459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Godos J, Federico A, Dallio M, Scazzina F. Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection. Int J Food Sci Nutr. 2017;68(1):18–27. https://doi.org/10.1080/09637486.2016.1214239.

    Article  CAS  PubMed  Google Scholar 

  3. Jones JL, Fernandez ML, McIntosh MS, Najm W, Calle MC, Kalynych C, Vukich C, Barona J, Ackermann D, Kim JE, Kumar V, Lott M, Volek JS, Lerman RH. A Mediterranean-style low-glycemic-load diet improves variables of metabolic syndrome in women, and addition of a phytochemical-rich medical food enhances benefits on lipoprotein metabolism. J Clin Lipidol. 2011;5(3):188–96. https://doi.org/10.1016/j.jacl.2011.03.002.

    Article  PubMed  Google Scholar 

  4. Billingsley HE, Carbone S. The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED. Nutr Diabetes. 2018;8(1):13. https://doi.org/10.1038/s41387-018-0025-1.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Manne V, Handa P, Kowdley KV. Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22(1):23–37. https://doi.org/10.1016/j.cld.2017.08.007.

    Article  PubMed  Google Scholar 

  6. Akhlaghi M. Non-alcoholic fatty liver disease: beneficial effects of flavonoids. Phytother Res. 2016;30(10):1559–71. https://doi.org/10.1002/ptr.5667.

    Article  CAS  Google Scholar 

  7. Suárez M, Boqué N, Del Bas JM, Mayneris-Perxachs J, Arola L, Caimari A. Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients. 2017;9(10):pii: E1052. https://doi.org/10.3390/nu9101052.

    Article  CAS  Google Scholar 

  8. Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30–43. https://doi.org/10.1038/ejcn.2017.58.

    Article  CAS  PubMed  Google Scholar 

  9. Galbete C, Schwingshackl L, Schwedhelm C, Boeing H, Schulze MB. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses. Eur J Epidemiol. 2018;33(10):909–31. https://doi.org/10.1007/s10654-018-0427-3.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

  11. Newcastle-Ottawa Scale adapted for cross-sectional studies. Available at: https://journals.plos.org/plosone/article/file?type=supplementary&id=info:doi/10.1371/journal.pone.0147601.s001

  12. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Chapter 16.4.5: Methods for incorporating cross-over trials into a meta-analysis [updated March 2011]. The Cochrane Collaboration; 2011. [cited 2016 Sep 20]. Available from: http://handbook.cochrane.org/chapter_16/16_4_5_methods_for_incorporating_cross_over_trials_into_a.htm

  13. Sedgwick P. What is publication bias in a meta-analysis? BMJ. 2015;351:h4419.

    Article  Google Scholar 

  14. Aller R, Burgueño Gomez B, Sigüenza R, Fernández-Rodríguez C, Fernández N, Antolín B, Durà M, Pina M, Lorenzo S, García C, de Luis Román D. Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. Rev Esp Enferm Dig. 2019;111(4):256–63. https://doi.org/10.17235/reed.2019.5926/2018.

    Article  PubMed  Google Scholar 

  15. Baratta F, Pastori D, Polimeni L, Bucci T, Ceci F, Calabrese C, Ernesti I, Pannitteri G, Violi F, Angelico F, Del Ben M. Adherence to Mediterranean diet and non-alcoholic fatty liver disease: effect on insulin resistance. Am J Gastroenterol. 2017;112(12):1832–9. https://doi.org/10.1038/ajg.2017.371.

    Article  CAS  PubMed  Google Scholar 

  16. Chan R, Wong VW, Chu WC, Wong GL, Li LS, Leung J, Chim AM, Yeung DK, Sea MM, Woo J, Chan FK, Chan HL. Diet-quality scores and prevalence of nonalcoholic fatty liver disease: a population study using proton-magnetic resonance spectroscopy. PLoS One. 2015;10(9):e0139310. https://doi.org/10.1371/journal.pone.0139310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Khalatbari-Soltani S, Imamura F, Brage S, De Lucia Rolfe E, Griffin SJ, Wareham NJ, Marques-Vidal P, Forouhi NG. The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study. BMC Med. 2019;17(1):19. https://doi.org/10.1186/s12916-019-1251-7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, Fragopoulou E, Zafiropoulou R, Manios Y, Papatheodoridis G. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014;33(4):678–83. https://doi.org/10.1016/j.clnu.2013.08.014.

    Article  CAS  PubMed  Google Scholar 

  19. Ma J, Hennein R, Liu C, Long MT, Hoffmann U, Jacques PF, Lichtenstein AH, Hu FB, Levy D. Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease. Gastroenterology. 2018;155(1):107–17. https://doi.org/10.1053/j.gastro.2018.03.038.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017;9(8):pii: E870. https://doi.org/10.3390/nu9080870.

    Article  CAS  Google Scholar 

  21. Biolato M, Manca F, Marrone G, Cefalo C, Racco S, Miggiano GA, Valenza V, Gasbarrini A, Miele L, Grieco A. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol. 2019;25(4):509–20. https://doi.org/10.3748/wjg.v25.i4.509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Katsagoni CN, Papatheodoridis GV, Ioannidou P, Deutsch M, Alexopoulou A, Papadopoulos N, Papageorgiou MV, Fragopoulou E, Kontogianni MD. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Br J Nutr. 2018;120(2):164–75. https://doi.org/10.1017/S000711451800137X.

    Article  CAS  PubMed  Google Scholar 

  23. Misciagna G, Del Pilar DM, Caramia DV, Bonfiglio C, Franco I, Noviello MR, Chiloiro M, Abbrescia DI, Mirizzi A, Tanzi M, Caruso MG, Correale M, Reddavide R, Inguaggiato R, Cisternino AM, Osella AR. Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinical trial. J Nutr Health Aging. 2017;21(4):404–12. https://doi.org/10.1007/s12603-016-0809-8.

    Article  CAS  PubMed  Google Scholar 

  24. Properzi C, O'Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, Tibballs J, MacQuillan GC, Garas G, Adams LA. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 2018;68(5):1741–54. https://doi.org/10.1002/hep.30076.

    Article  CAS  PubMed  Google Scholar 

  25. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA, Wilson AM. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–43. https://doi.org/10.1016/j.jhep.2013.02.012.

    Article  CAS  PubMed  Google Scholar 

  26. Calvaruso V, Craxì A. Implication of normal liver enzymes in liver disease. J Viral Hepat. 2009;16(8):529–36. https://doi.org/10.1111/j.1365-2893.2009.01150.x.

    Article  PubMed  Google Scholar 

  27. Yki-Järvinen H. Diagnosis of non-alcoholic fatty liver disease (NAFLD). Diabetologia. 2016;59(6):1104–11. https://doi.org/10.1007/s00125-016-3944-1.

    Article  CAS  PubMed  Google Scholar 

  28. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211–8.

    Article  CAS  Google Scholar 

  29. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–95.

    Article  Google Scholar 

  30. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792–8. https://doi.org/10.1002/hep.22429.

    Article  CAS  PubMed  Google Scholar 

  31. Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE, Larsson A, Johansson L, Ahlström H, Arner P, Dahlman I, Risérus U. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes. 2014;63(7):2356–68. https://doi.org/10.2337/db13-1622.

    Article  PubMed  Google Scholar 

  32. Chen X, Li L, Liu X, Luo R, Liao G, Li L, Liu J, Cheng J, Lu Y, Chen Y. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Life Sci. 2018;203:291–304. https://doi.org/10.1016/j.lfs.2018.04.022.

    Article  CAS  PubMed  Google Scholar 

  33. Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol. 2001;281(4):G865–9.

    Article  CAS  Google Scholar 

  34. Scorletti E, Byrne CD. Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action. Mol Asp Med. 2018;64:135–46. https://doi.org/10.1016/j.mam.2018.03.001.

    Article  CAS  Google Scholar 

  35. Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol. 2010;80(10):1601–12. https://doi.org/10.1016/j.bcp.2010.07.031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol. 2015;6(4):110–9. https://doi.org/10.4291/wjgp.v6.i4.110.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms. Liver Int. 2017;37(7):936–49. https://doi.org/10.1111/liv.13435.

    Article  CAS  PubMed  Google Scholar 

  38. Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol. 2018;24(19):2083–94. https://doi.org/10.3748/wjg.v24.i19.2083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. https://doi.org/10.3390/nu8030128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Li D, Wahlqvist ML, Sinclair AJ. Advances in n-3 polyunsaturated fatty acid nutrition. Asia Pac J Clin Nutr. 2019;28(1):1–5. https://doi.org/10.6133/apjcn.201903_28(1).0001.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Community Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Razi Blvd, Shiraz, Iran

    Masoumeh Akhlaghi

  2. Department of Clinical Nutrition, School of Nutrition and Food Sciences, Razi Blvd, Shiraz, Iran

    Maryam Ghasemi-Nasab & Maryamsadat Riasatian

Authors
  1. Masoumeh Akhlaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Ghasemi-Nasab
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryamsadat Riasatian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masoumeh Akhlaghi.

Ethics declarations

Conflict of interest

Authors have no conflict of interest to declare.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akhlaghi, M., Ghasemi-Nasab, M. & Riasatian, M. Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations. J Diabetes Metab Disord 19, 575–584 (2020). https://doi.org/10.1007/s40200-019-00475-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-019-00475-2

Keywords

Search

Navigation